- NCIt
- C223845
Loading cancer entity…
Loading cancer entity…
Clinical trials
21 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (2)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06205316 | SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma | active not recruiting | Phase 3 | 118 | Mayo ClinicOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT04248452 | Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body | active not recruiting | Phase 3 | 314 | ECOG-ACRIN Cancer Research GroupNETWORK | 1 | Sep 14, 2026 |
| clinicaltrials |
| NCT07578116 | Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis | not yet recruiting | Phase 3 | 562 | SWOG Cancer Research NetworkNETWORK | 0 | May 27, 2026 | clinicaltrials |
| NCT06587490 | Total RadIoTherapy of Oligometastatic caNcerS(TRITONS) | recruiting | Phase 3 | 300 | University of California, San DiegoOTHER | 1 | Oct 14, 2025 | clinicaltrials |
| NCT05303714 | PIPAC in Multimodal Therapy for Patients with Oligometastatic Peritoneal Gastric Cancer(PIPAC_VEROne) | recruiting | Phase 3 | 98 | Azienda Ospedaliera Universitaria Integrata VeronaOTHER | 1 | Feb 21, 2025 | clinicaltrials |
Data updated 13 days agoSource updated Sep 17, 2026source: clinicaltrials